Published Date: 26 Apr 2023
In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.
Read Full News1.
Lesser-known lobular breast cancer on the rise in U.S. women
2.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
3.
It Is Not Just the Royals Who Go Through Cancer.
4.
Pressing the Sleep button could have a positive impact on cognition.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
The Unseen Danger of Anal Cancer: How to Protect Yourself
2.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
3.
Evolution of Cancer Care Through Developmental Therapeutics
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation